Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04194489 · ClinicalTrials.gov registry record · NA

Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention

A NA study, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
171
Enrollment target

NCT04194489: Completed NA study, sponsored by University of Rochester.

NCT04194489 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 171 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04194489, a NA study, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
171 participants
Enrollment target

Study Summary

The purpose of this study is to test a new smartphone "app" for parents/caregivers of children with fetal alcohol spectrum disorder (FASD). The app is called Families Moving Forward (FMF) Connect. The goal of the app is to provide parents/caregivers with useful information to help manage their children's condition and obtain peer support.

Primary Outcome

The Eyberg Child Behavior Inventory measures the intensity of child behavior problems. Scores are presented as T-scores with a mean of 50 and a standard deviation of 10. A T-score of 60 or higher is considered clinically significant. Higher scores indicate more intense behavior problems. An effect size of 0.2 is small, 0.5 is medium and 0.8 is large.

Interventions

  • OTHER FMF Connect

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2020-01-31
Est. Completion 2021-07-31
Phase NA
University of Rochester

636 total trials

What the finished NCT04194489 record still lists

NCT04194489 is an interventional study that assigns participants to a tested intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).

The record links to 0 conditions, and to 1 intervention - of which FMF Connect is the first listed.

NCT04194489 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04194489 about?

NCT04194489 is a clinical study titled "Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention". The purpose of this study is to test a new smartphone "app" for parents/caregivers of children with fetal alcohol spectrum disorder (FASD). The app is called Families Moving Forward (FMF) Connect. The goal of the app is to provide parents/caregivers with useful information to help manage their child...

What is the current status of trial NCT04194489?

This trial is currently completed. It is a NA study. The enrollment target is 171 participants. The study started on 2020-01-31. Estimated completion is 2021-07-31.

What interventions are being tested in trial NCT04194489?

The interventions under investigation include: FMF Connect (OTHER).

Who is sponsoring clinical trial NCT04194489?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04194489's enrollment target sits among peer trials

171 612th of 2000 higher than 1,387 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02641145 · 171 participants · NA

    Molecular Imaging of Primary Amyloid Cardiomyopathy

  • NCT05541029 · 171 participants · NA

    Music Listening: A Mechanistic Trial

  • NCT05561127 · 171 participants · Phase 3

    Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel

  • NCT05592938 · 171 participants · NA

    Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04194489, the US trial registry maintained by the National Library of Medicine. NCT04194489 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.